Loading clinical trials...
Loading clinical trials...
The purpose of this randomized clinical trial is to evaluate the utility of noninvasive markers for the detection of advanced fibrosis in patients newly diagnosed with Non-alcoholic Fatty Liver Diseas...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Fundación Clínica Médica Sur
NCT06623539 · Non Alcoholic Fatty Liver Disease
NCT07104786 · Non Alcoholic Fatty Liver Disease
NCT04442620 · Non Alcoholic Fatty Liver Disease
NCT03300661 · Non Alcoholic Fatty Liver Disease, Lifestyle, and more
NCT02248311 · Type2 Diabetes Mellitus, Microangiopathy, and more
Medica Sur Clinic & Foundation
Mexico City, Mexico City
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions